Polio in New York: How to Recognize and Report Polio, and Reinforce Routine Childhood Polio Vaccination

At a glance

During this COCA Call, presenters will discuss the history of polio in the United States and the current New York state outbreak. They will also review clinical aspects of poliovirus infection, how to report suspected cases, and recommendations for polio vaccination in the United States.

Webinar

View Slides
View Transcript

Overview

The Centers for Disease Control and Prevention (CDC) is investigating a case of poliomyelitis, or paralytic polio, in New York state in an unvaccinated patient who presented to an emergency room with lower limb weakness and fever. CDC urges all healthcare providers to ensure their patients are current on the primary polio vaccination series. Healthcare providers should consider polio in the differential diagnosis of patients with sudden onset of limb weakness, especially in unvaccinated individuals and those with recent international travel to places where poliovirus is circulating.

During this COCA Call, presenters will discuss the history of polio in the United States and the current New York state outbreak. They will also review clinical aspects of poliovirus infection, how to report suspected cases, and recommendations for polio vaccination in the United States.

Presenters

Farrell Tobolowsky, DO, MS
LCDR, U.S. Public Health Service
Clinical Task Force Lead
2022 NYS Polio Response
Centers for Disease Control and Prevention

Emily Lutterloh, MD, MPH
Director, Division of Epidemiology
New York State Department of Health

Janell Routh, MD, MHS
CAPT, U.S. Public Health Service
Incident Manager
2022 NYS Polio Response
Centers for Disease Control and Prevention

Georgina Peacock, MD, MPH
Director, Division of Immunization Services
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Call Objectives

COCA Call Objectives

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC's role in the topic covered during the presentation.
  3. Describe the topic's implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.

Activity-specific Objectives

  1. Discuss the history of polio globally and in the United States.
  2. Outline the current investigation and response to the case of paralytic polio in New York.
  3. Describe how to recognize, diagnose, and report suspected paralytic polio cases in the United States.
  4. Distinguish the differences between inactivated polio vaccine (IPV) and oral polio vaccine (OPV) and the importance of maintaining high polio vaccination coverage.

Continuing Education

To receive continuing education (CE) for WC4520-090122 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Polio in New York: How to Recognize and Report Polio, and Reinforce Routine Childhood Polio Vaccination, Thursday, September 1, 2022, please visit TCEO and follow these 9 Simple Steps by Monday, October 3, 2022.

To receive continuing education (CE) for WD4520-090122 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Polio in New York: How to Recognize and Report Polio, and Reinforce Routine Childhood Polio Vaccination, Thursday, September 1, 2022, (Web on Demand), please visit TCEO and follow these 9 Simple Steps between Tuesday, October 4, 2022, and Friday, October 4, 2024.

In support of improving patient care, the Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Jointly Accredited Provider logo
CDC is a Jointly Accredited Provider in Interprofessional Continuing Education.

CME: The Centers for Disease Control and Prevention designates this activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA CME: The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 12/13/2023. PAs should only claim credit commensurate with the extent of their participation

CNE: The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.

CPE: The Centers for Disease Control and Prevention designated this (Knowledge-based) event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-22-116-L04-P and enduring is JA4008229-0000-22-117-H04-P.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1. Continuing Competency credits available are 1. CDC provider number 98614.

AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program's validity or relevancy to the veterinary profession.

For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.

DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use, with the exception of Dr. Janell Routh's discussion of Pocapavir as an IND investigative agent to stop poliovirus shedding.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Target Audience

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians

Contact Information

  • Contact Information: coca@cdc.gov
  • Support/Funding: Centers for Disease Control and Prevention, Emergency Risk Communication Branch
  • Method of Participation: You may participate in the educational activity by viewing the program information above.
Print
Content Source: